Cryptotanshinone Is a Intervention for ER-Positive Breast Cancer: An Integrated Approach to the Study of Natural Product Intervention Mechanisms

Background: Resistance to endocrine therapy has hampered clinical treatment in patients with ER-positive breast cancer (BRCA). Studies have confirmed that cryptotanshinone (CPT) has cytotoxic effects on BRCA cells and can significantly inhibit the proliferation and metastasis of ER-positive cancer c...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Huayao, Gao, Chundi, Liang, Qing, Liu, Cun, Liu, Lijuan, Zhuang, Jing, Yang, Jing, Zhou, Chao, Feng, Fubin, Sun, Changgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832090/
https://www.ncbi.nlm.nih.gov/pubmed/33505309
http://dx.doi.org/10.3389/fphar.2020.592109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832090/
https://www.ncbi.nlm.nih.gov/pubmed/33505309
http://dx.doi.org/10.3389/fphar.2020.592109

Ejemplares similares